These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38467612)

  • 1. A first-in-class TIMM44 blocker inhibits bladder cancer cell growth.
    Zhang L; Shi X; Zhang L; Mi Y; Zuo L; Gao S
    Cell Death Dis; 2024 Mar; 15(3):204. PubMed ID: 38467612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mitochondrial protein TIMM44 is required for angiogenesis in vitro and in vivo.
    Ma ZR; Li HP; Cai SZ; Du SY; Chen X; Yao J; Cao X; Zhen YF; Wang Q
    Cell Death Dis; 2023 May; 14(5):307. PubMed ID: 37147302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIMM44 is a potential therapeutic target of human glioma.
    Guo YZ; Chen G; Huang M; Wang Y; Liu YY; Jiang Q; Cao C; Liu F
    Theranostics; 2022; 12(17):7586-7602. PubMed ID: 36438483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo.
    Sun X; Shi C; Dai J; Zhang MQ; Pei DS; Yang L
    Cell Death Dis; 2024 May; 15(5):346. PubMed ID: 38769124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting POLRMT by IMT1 inhibits colorectal cancer cell growth.
    Wang H; Liu Y; Lu XS; Wu Y; Gu W; Yin G
    Cell Death Dis; 2024 Sep; 15(9):643. PubMed ID: 39227564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting POLRMT by a first-in-class inhibitor IMT1 inhibits osteosarcoma cell growth in vitro and in vivo.
    Kong Y; Li X; Zhang H; Fu B; Jiang HY; Yang HL; Dai J
    Cell Death Dis; 2024 Jan; 15(1):57. PubMed ID: 38228583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting SphK1/2 by SKI-178 inhibits prostate cancer cell growth.
    Jin L; Zhu J; Yao L; Shen G; Xue BX; Tao W
    Cell Death Dis; 2023 Aug; 14(8):537. PubMed ID: 37604912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mitochondrial protein YME1 Like 1 is important for non-small cell lung cancer cell growth.
    Xia Y; He C; Hu Z; Wu Z; Hui Y; Liu YY; Mu C; Zha J
    Int J Biol Sci; 2023; 19(6):1778-1790. PubMed ID: 37063426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the mitochondrial protein POLRMT as a potential therapeutic target of prostate cancer.
    Li X; Yao L; Wang T; Gu X; Wu Y; Jiang T
    Cell Death Dis; 2023 Oct; 14(10):665. PubMed ID: 37816734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the mitochondrial protein ADCK2 as a therapeutic oncotarget of NSCLC.
    Zhang JZ; Liu J; Xu YX; Pu WY; Shen MJ; Jiang KQ; Yang YL; Lu J; Deng Z; Yang Y; Xu WH
    Int J Biol Sci; 2022; 18(16):6163-6175. PubMed ID: 36439873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paeonol inhibits proliferation and induces cell apoptosis of human T24 and 5637 bladder cancer cells in vitro and in vivo.
    Zhang JJ; Cai LJ; Pang K; Dong Y; Zhang ZG; Li BB; Li R; Han CH
    Clin Transl Oncol; 2021 Mar; 23(3):601-611. PubMed ID: 32691366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoquercitrin inhibits bladder cancer progression in vivo and in vitro by regulating the PI3K/Akt and PKC signaling pathways.
    Chen F; Chen X; Yang D; Che X; Wang J; Li X; Zhang Z; Wang Q; Zheng W; Wang L; Wang X; Song X
    Oncol Rep; 2016 Jul; 36(1):165-72. PubMed ID: 27177091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pegylated Recombinant Human Arginase 1 Induces Autophagy and Apoptosis via the ROS-Activated AKT/mTOR Pathway in Bladder Cancer Cells.
    Zhao Z; Zhang P; Li W; Wang D; Ke C; Liu Y; Ho JC; Cheng PN; Xu S
    Oxid Med Cell Longev; 2021; 2021():5510663. PubMed ID: 33791071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A first-in-class POLRMT specific inhibitor IMT1 suppresses endometrial carcinoma cell growth.
    Li SP; Ou L; Zhang Y; Shen FR; Chen YG
    Cell Death Dis; 2023 Feb; 14(2):152. PubMed ID: 36823110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOXC13-driven TIMM13 overexpression promotes osteosarcoma cell growth.
    Han Q; Yan P; Song R; Liu F; Tian Q
    Cell Death Dis; 2023 Jul; 14(7):398. PubMed ID: 37407582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative factor decreases Akt phosphorylation and alters gene expression via CKAP4 in T24 bladder carcinoma cells.
    Shahjee HM; Koch KR; Guo L; Zhang CO; Keay SK
    J Exp Clin Cancer Res; 2010 Dec; 29(1):160. PubMed ID: 21143984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
    Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
    Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Caryophyllene induces apoptosis and inhibits cell proliferation by deregulation of STAT-3/mTOR/AKT signaling in human bladder cancer cells: An in vitro study.
    Yu X; Liao B; Zhu P; Cheng S; Du Z; Jiang G
    J Biochem Mol Toxicol; 2021 Oct; 35(10):e22863. PubMed ID: 34318533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin-mediated downregulation of ZNF746 suppresses bladder tumorigenesis mainly through inhibiting the AKT-MMP-9 signaling pathway.
    Chen YT; Yang CC; Shao PL; Huang CR; Yip HK
    J Pineal Res; 2019 Jan; 66(1):e12536. PubMed ID: 30372570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
    Luo HB; Li B; Yuan WG; Xu CR
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.